Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (5): 319-320.
HUANG Si-chao, YUAN Xiao-bin,ZHONG Jin-song,QIAN Jia-jian
Received:2018-01-15
Revised:2018-06-21
Online:2018-05-20
Published:2018-06-21
Contact:
陈洁,女,本科,主任药师,药理学及临床药学。E-mail: mlfzp@126.com
CLC Number:
HUANG Si-chao, YUAN Xiao-bin,ZHONG Jin-song,QIAN Jia-jian. One Case of Acute Liver Injury and Thrombocytopenia Induced by Troxerutin and Cerebroprotein Hydrolysate Injection in a Pediatric Patient[J]. Chinese Journal of Pharmacovigilance, 2018, 15(5): 319-320.
| [1] 中国抗癌协会临床肿瘤学协作专业委员会. 肿瘤化疗所致血小板减少症诊疗中国专家共识(2014版) [J]. 中华肿瘤杂志, 2014, 36(11):876-879. [2] 曹婉鑫, 唐瑶, 陈洋. 曲克芦丁药理作用的研究进展[J]. 中国食物与营养, 2015, 21(9):73-75. [3] 邱海军, 马海朋. 曲克芦丁脑蛋白水解物对烟雾病患者神经功能及血小板计数的影响[J]. 中国实用神经疾病杂志, 2016, 19(22):96-98. [4] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 临床肝胆病杂志, 2015, 31(11):1752-1769. [5] Chalasani N P, Hayashi P H, Bonkovsky H L, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury[J]. Am J Gastroenterol, 2014, 109(7):950-967. [6] 冯亚楠, 刘欣欣, 李永辉, 等. 61例曲克芦丁制剂不良反应的文献分析[J]. 中国药物警戒, 2015, 12(11):683-686. [7] 徐伏莲, 赵志刚. 脑蛋白水解物不良反应文献分析[J]. 中国医院药学杂志, 2007, 27(7):1005-1006. [8] 戴华. 曲克芦丁注射液致肝功能异常[J]. 药物不良反应杂志, 2003, 5(3):202-203. [9] 王斌哲, 王瑞华. 曲克芦丁(维脑路通)致肝损伤1例[J]. 西北国防医学杂志, 2010, 31(4):249. [10] 代东伶, 文飞球, 蔡华波, 等. 儿童重度肝功能损害临床特点分析[J]. 临床儿科杂志, 2015, 33(10):846-849. [11] Amin M D, Harpavat S, Leung D H. Drug-induced liver injury in children[J]. Curr Opin Pediatr, 2015, 27(5):625-633. [12] 都丽萍, 梅丹. 药源性血小板减少症的发病机制和临床表现及防治[J]. 药物不良反应杂志, 2007, 9(6):414-419. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
